Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRASS
2018-002345-12Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in Raynaud disease, sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Raynaud disease
Beyond the preview
Go deeper on 2018-002345-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002345-12.